Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INTERogating Cancer for Etiology, Prevention and Therapy Navigation (INTERCEPTioN)

NCT06008392 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06008392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06008392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INTERogating Cancer for Etiology, Prevention and Therapy Navigation (INTERCEPTioN)
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
October 12, 2023
Completion date
September 30, 2033
Enrollment
500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, cancer gene mutation, hematopoietic and lymphoid system neoplasm, malignant solid neoplasm, pan gene mutation